{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:49:31Z","timestamp":1787165371732,"version":"build-2736575974"},"reference-count":82,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.pharma.2024.07.008","type":"journal-article","created":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T21:47:28Z","timestamp":1722376048000},"page":"195-210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Enhancing drug bioavailability for Parkinson's disease: The promise of chitosan delivery mechanisms"],"prefix":"10.1016","volume":"83","author":[{"given":"Mohammad Arshad Javed","family":"Shaikh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawan","family":"Bagiyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramkumar","family":"Pillappan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh Kumar","family":"Chellappan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parteek","family":"Prasher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Jakhmola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thakur Gurjeet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harish","family":"Dureja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal","family":"Dua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.pharma.2024.07.008_bib0005","doi-asserted-by":"crossref","first-page":"11609","DOI":"10.1021\/acsami.0c22112","article-title":"Multifunctional nanoprobe for the delivery of therapeutic siRNA and real-time molecular imaging of Parkinson's disease biomarkers","volume":"13","author":"Li","year":"2021","journal-title":"ACS Appl Mater Interfaces"},{"issue":"2","key":"10.1016\/j.pharma.2024.07.008_bib0010","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.mcna.2018.10.014","article-title":"Parkinson's disease","volume":"103","author":"Reich","year":"2019","journal-title":"Med Clin N Am"},{"issue":"1","key":"10.1016\/j.pharma.2024.07.008_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics11010026","article-title":"Fabrication, optimization, and evaluation of rotigotine-loaded chitosan nanoparticles for nose-to-brain delivery","volume":"11","author":"Tzeyung","year":"2019","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.pharma.2024.07.008_bib0020","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2741\/S415","article-title":"Parkinson's disease: a review","volume":"6S","author":"Beitz","year":"2014","journal-title":"Front Biosci Scholar"},{"issue":"4","key":"10.1016\/j.pharma.2024.07.008_bib0025","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2174\/1871527316666170328113309","article-title":"Neuroprotective effects of citrus fruit-derived flavonoids, nobiletin and tangeretin in Alzheimer's and Parkinson's disease","volume":"16","author":"Braidy","year":"2017","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"7","key":"10.1016\/j.pharma.2024.07.008_bib0030","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.amjmed.2019.03.001","article-title":"Parkinson's disease and Parkinsonism","volume":"132","author":"Hayes","year":"2019","journal-title":"Am J Med"},{"issue":"8","key":"10.1016\/j.pharma.2024.07.008_bib0035","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","article-title":"Epidemiology of Parkinson's disease","volume":"124","author":"Tysnes","year":"2017","journal-title":"J Neural Transm"},{"issue":"1","key":"10.1016\/j.pharma.2024.07.008_bib0040","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40035-020-00191-5","article-title":"Freezing of gait in Parkinson's disease: pathophysiology, risk factors and treatments","volume":"9","author":"Gao","year":"2020","journal-title":"Transl Neurodegen"},{"issue":"5","key":"10.1016\/j.pharma.2024.07.008_bib0045","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","article-title":"Challenges in the diagnosis of Parkinson's disease","volume":"20","author":"Tolosa","year":"2021","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.pharma.2024.07.008_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104700","article-title":"Autonomic dysfunction in Parkinson's disease: implications for pathophysiology, diagnosis, and treatment","volume":"134","author":"Chen","year":"2020","journal-title":"Neurobiol Dis"},{"issue":"9","key":"10.1016\/j.pharma.2024.07.008_bib0055","doi-asserted-by":"crossref","first-page":"754","DOI":"10.2174\/1389557519666191104110908","article-title":"Parkinson's disease: a review from pathophysiology to treatment","volume":"20","author":"Marino","year":"2019","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.pharma.2024.07.008_bib0060","doi-asserted-by":"crossref","first-page":"103849","DOI":"10.1016\/j.jddst.2022.103849","article-title":"Oligonucleotides: a novel area of interest for drug delivery in neurodegenerative diseases","volume":"77","author":"Saad","year":"2022","journal-title":"J Drug Deliv Sci Technol"},{"issue":"17","key":"10.1016\/j.pharma.2024.07.008_bib0065","doi-asserted-by":"crossref","DOI":"10.3390\/polym14173558","article-title":"Potential medical applications of chitooligosaccharides","volume":"14","author":"Anil","year":"2022","journal-title":"Polymers"},{"issue":"10","key":"10.1016\/j.pharma.2024.07.008_bib0070","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1038\/s41401-020-00594-0","article-title":"Chitosan oligosaccharide modified liposomes enhance lung cancer delivery of paclitaxel","volume":"42","author":"Miao","year":"2021","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.pharma.2024.07.008_bib0075","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-12-821058-1.00005-8","article-title":"Chitosan: a versatile biopolymer","volume":"1\u201311","author":"Roy","year":"2022","journal-title":"Chitosan Biomed Appl"},{"issue":"2","key":"10.1016\/j.pharma.2024.07.008_bib0080","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21020487","article-title":"Chitosan derivatives and their application in biomedicine","volume":"21","author":"Wang","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pharma.2024.07.008_bib0085","doi-asserted-by":"crossref","first-page":"104196","DOI":"10.1016\/j.jddst.2023.104196","article-title":"Chitosan-based nano drug delivery system for lung cancer","volume":"81","author":"Kazmi","year":"2023","journal-title":"J Drug Deliv Sci Technol"},{"issue":"1\u20132","key":"10.1016\/j.pharma.2024.07.008_bib0090","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ijpharm.2015.04.054","article-title":"In vitro and in vivo evaluation of \u03949-tetrahidrocannabinol\/PLGA nanoparticles for cancer chemotherapy","volume":"487","author":"Mart\u00edn-Banderas","year":"2015","journal-title":"Int J Pharm"},{"key":"10.1016\/j.pharma.2024.07.008_bib0095","doi-asserted-by":"crossref","first-page":"104619","DOI":"10.1016\/j.jddst.2023.104619","article-title":"Harnessing chitosan-adorned liposomes for enhanced drug delivery in cancer","volume":"85","author":"Shaikh","year":"2023","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.pharma.2024.07.008_bib0100","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.matchemphys.2017.04.018","article-title":"Carbohydrate polymer based pH-sensitive IPN microgels: synthesis, characterization and drug release characteristics","volume":"195","author":"Eswaramma","year":"2017","journal-title":"Mater Chem Phys"},{"issue":"2","key":"10.1016\/j.pharma.2024.07.008_bib0105","first-page":"13","article-title":"Preparation and evaluation of polyvinyl alcohol transdermal membranes of salbutamol sulphate","volume":"2","author":"Kulkarni","year":"2010","journal-title":"Int J Curr Pharm Res"},{"key":"10.1016\/j.pharma.2024.07.008_bib0110","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ijbiomac.2020.02.131","article-title":"HER2 targeted biological macromolecule modified liposomes for improved efficacy of capecitabine in breast cancer","volume":"150","author":"Singh","year":"2020","journal-title":"Int J Biol Macromol"},{"issue":"19","key":"10.1016\/j.pharma.2024.07.008_bib0115","doi-asserted-by":"crossref","first-page":"22074","DOI":"10.1021\/acsami.9b22440","article-title":"Stimuli-responsive polysaccharide enveloped liposome for targeting and penetrating delivery of survivin-shRNA into breast tumor","volume":"12","author":"Chen","year":"2020","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.pharma.2024.07.008_bib0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fbioe.2022.1013541","article-title":"Targeted delivery of 5-fluorouracil, miR-532-3p, and si-KRAS to the colorectal tumor using layer-by-layer liposomes","volume":"10","author":"Shahidi","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"issue":"24","key":"10.1016\/j.pharma.2024.07.008_bib0125","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.2217\/nnm-2020-0167","article-title":"Formulation and in vivo efficacy study of cetuximab decorated targeted bioadhesive nanomedicine for non-small-cell lung cancer therapy","volume":"15","author":"Viswanadh","year":"2020","journal-title":"Nanomedicine"},{"issue":"10","key":"10.1016\/j.pharma.2024.07.008_bib0130","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3390\/brainsci9100275","article-title":"Brain sciences neuroprotective and antioxidant effect of naringenin-loaded nanoparticles for","volume":"9","author":"Md","year":"2019","journal-title":"Brain Sci"},{"key":"10.1016\/j.pharma.2024.07.008_bib0135","doi-asserted-by":"crossref","first-page":"117435","DOI":"10.1016\/j.carbpol.2020.117435","article-title":"Chitosan nanocarrier for FTY720 enhanced delivery retards Parkinson's disease via PP2A-EzH2 signaling in vitro and ex vivo","volume":"254","author":"Sardoiwala","year":"2021","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.pharma.2024.07.008_bib0140","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ijbiomac.2020.11.207","article-title":"Chitosan coated synergistically engineered nanoemulsion of Ropinirole and nigella oil in the management of Parkinson's disease: formulation perspective and In vitro and In vivo assessment","volume":"167","author":"Nehal","year":"2021","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.pharma.2024.07.008_bib0145","first-page":"1907","article-title":"Effects of chemically modified nanostructured PLGA on functioning of lung and breast cancer cells","volume":"8","author":"Zhang","year":"2013","journal-title":"Int J Nanomed"},{"issue":"1","key":"10.1016\/j.pharma.2024.07.008_bib0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1556-276X-8-66","article-title":"Thiolated chitosan-modified PLA-PCL-TPGS nanoparticles for oral chemotherapy of lung cancer","volume":"8","author":"Jiang","year":"2013","journal-title":"Nanoscale Res Lett"},{"key":"10.1016\/j.pharma.2024.07.008_bib0155","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1016\/j.ijbiomac.2018.09.032","article-title":"N,N,N-trimethyl chitosan modified flaxseed oil based mucoadhesive neuronanoemulsions for direct nose to brain drug delivery","volume":"120","author":"Pardeshi","year":"2018","journal-title":"Int J Biol Macromol"},{"issue":"6","key":"10.1016\/j.pharma.2024.07.008_bib0160","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1586\/14737175.2015.1036743","article-title":"Nano-ropinirole for the management of Parkinsonism: blood-brain pharmacokinetics and carrier localization","volume":"15","author":"Mustafa","year":"2015","journal-title":"Expert Rev Neurother"},{"issue":"1","key":"10.1016\/j.pharma.2024.07.008_bib0165","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14010147","article-title":"Novel nanoparticles based on N,O-carboxymethyl chitosan-dopamine amide conjugate for nose-to-brain delivery","volume":"14","author":"Trapani","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.pharma.2024.07.008_bib0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119148","article-title":"Nose to brain delivery of rotigotine loaded chitosan nanoparticles in human SH-SY5Y neuroblastoma cells and animal model of Parkinson's disease","volume":"579","author":"Bhattamisra","year":"2020","journal-title":"Int J Pharm"},{"key":"10.1016\/j.pharma.2024.07.008_bib0175","doi-asserted-by":"crossref","first-page":"109842","DOI":"10.1016\/j.cbi.2022.109842","article-title":"Nuclear factor-kappa B (NF-\u03baB) inhibition as a therapeutic target for plant nutraceuticals in mitigating inflammatory lung diseases","volume":"354","author":"Alharbi","year":"2022","journal-title":"Chem Biol Interact"},{"issue":"7","key":"10.1016\/j.pharma.2024.07.008_bib0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ma12071176","article-title":"Chitosan nanoparticles rescue rotenone-mediated cell death","volume":"12","author":"Ahlawat","year":"2019","journal-title":"Materials"},{"issue":"16","key":"10.1016\/j.pharma.2024.07.008_bib0185","doi-asserted-by":"crossref","first-page":"18964","DOI":"10.1021\/acsami.9b21215","article-title":"Chitosan-ellagic acid nanohybrid for mitigating rotenone-induced oxidative stress","volume":"12","author":"Ahlawat","year":"2020","journal-title":"ACS Appl Mater Interfaces"},{"issue":"1","key":"10.1016\/j.pharma.2024.07.008_bib0190","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s40199-019-00325-9","article-title":"In Silico design of AVP (4-5) peptide and synthesis, characterization and in vitro activity of chitosan nanoparticles","volume":"28","author":"Kecel-Gunduz","year":"2020","journal-title":"DARU J Pharm Sci"},{"key":"10.1016\/j.pharma.2024.07.008_bib0195","doi-asserted-by":"crossref","first-page":"119689","DOI":"10.1016\/j.carbpol.2022.119689","article-title":"Sodium alginate based drug delivery in management of breast cancer","volume":"292","author":"Shaikh","year":"2022","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.pharma.2024.07.008_bib0200","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jconrel.2018.12.007","article-title":"inPentasomes: an innovative nose-to-brain pentamidine delivery blunts MPTP parkinsonism in mice","volume":"294","author":"Rinaldi","year":"2019","journal-title":"J Controlled Release"},{"key":"10.1016\/j.pharma.2024.07.008_bib0205","doi-asserted-by":"crossref","first-page":"173139","DOI":"10.1016\/j.ejphar.2020.173139","article-title":"Molecular mechanisms of action of naringenin in chronic airway diseases","volume":"879","author":"Chin","year":"2020","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharma.2024.07.008_bib0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105604","article-title":"Nano-based drug delivery systems used as vehicles to enhance polyphenols therapeutic effect for diabetes mellitus treatment","volume":"169","author":"Rocha","year":"2021","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.pharma.2024.07.008_bib0215","doi-asserted-by":"crossref","first-page":"113257","DOI":"10.1016\/j.jpba.2020.113257","article-title":"In vitro investigations on dopamine loaded solid lipid nanoparticles","volume":"185","author":"Cometa","year":"2020","journal-title":"J Pharm BiomedAnal"},{"issue":"9996","key":"10.1016\/j.pharma.2024.07.008_bib0220","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson's disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.pharma.2024.07.008_bib0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-43772-9","article-title":"Amido-bridged nucleic acid (AmNA)-modified antisense oligonucleotides targeting \u03b1-synuclein as a novel therapy for Parkinson's disease","volume":"9","author":"Uehara","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.pharma.2024.07.008_bib0230","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.colsurfb.2018.05.049","article-title":"Protection of dopamine towards autoxidation reaction by encapsulation into non-coated- or chitosan- or thiolated chitosan-coated-liposomes","volume":"170","author":"Trapani","year":"2018","journal-title":"Colloids Surfaces B: Biointerfaces"},{"issue":"4","key":"10.1016\/j.pharma.2024.07.008_bib0235","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/jbm.b.32667","article-title":"Reversal of diabetes by \u03b2tC3 cells encapsulated in alginate beads generated by emulsion and internal gelation","volume":"100 B","author":"Hoesli","year":"2012","journal-title":"J Biomed Mater Res Part B Appl Biomater"},{"key":"10.1016\/j.pharma.2024.07.008_bib0240","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.ijbiomac.2017.07.130","article-title":"Injectable hydrogel based on quaternized chitosan, gelatin and dopamine as localized drug delivery system to treat Parkinson's disease","volume":"105","author":"Ren","year":"2017","journal-title":"Int J Biol Macromol"},{"issue":"8","key":"10.1016\/j.pharma.2024.07.008_bib0245","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1016\/j.nano.2018.08.004","article-title":"Pharmacokinetics and pharmacodynamics of intranasally administered selegiline nanoparticles with improved brain delivery in Parkinson's disease","volume":"14","author":"Sridhar","year":"2018","journal-title":"Nanomed Nanotechnol Biol Med"},{"issue":"2","key":"10.1016\/j.pharma.2024.07.008_bib0250","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1080\/1061186X.2017.1350858","article-title":"Brain targeted delivery of mucoadhesive thermosensitive nasal gel of selegiline hydrochloride for treatment of Parkinson's disease","volume":"26","author":"Sridhar","year":"2018","journal-title":"J Drug Target"},{"issue":"15","key":"10.1016\/j.pharma.2024.07.008_bib0255","doi-asserted-by":"crossref","first-page":"17936","DOI":"10.1021\/acsami.9b21528","article-title":"Injectable and in situ-formable thiolated chitosan-coated liposomal hydrogels as curcumin carriers for prevention of in vivo breast cancer recurrence","volume":"12","author":"Li","year":"2020","journal-title":"ACS Appl Mater Interfaces"},{"issue":"10","key":"10.1016\/j.pharma.2024.07.008_bib0260","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.3109\/03639045.2014.991400","article-title":"Design, characterization, and evaluation of intranasal delivery of ropinirole-loaded mucoadhesive nanoparticles for brain targeting","volume":"41","author":"Jafarieh","year":"2015","journal-title":"Drug Dev Ind Pharm"},{"issue":"6","key":"10.1016\/j.pharma.2024.07.008_bib0265","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1080\/03639045.2021.1957919","article-title":"Influence of chitosan thioglycolic acid conjugate in improving bioavailability of an antiparkinson drug; Rasagiline Mesylate from transdermal patch","volume":"47","author":"Rohith","year":"2021","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.pharma.2024.07.008_bib0270","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijbiomac.2017.12.056","article-title":"Pramipexole dihydrochloride loaded chitosan nanoparticles for nose to brain delivery: development, characterization and in vivo anti-Parkinson activity","volume":"109","author":"Raj","year":"2018","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.pharma.2024.07.008_bib0275","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ijbiomac.2021.09.115","article-title":"Current update on psyllium and alginate incorporate for interpenetrating polymer network (IPN) and their biomedical applications","volume":"191","author":"Shaikh","year":"2021","journal-title":"Int J Biol Macromol"},{"issue":"3","key":"10.1016\/j.pharma.2024.07.008_bib0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ph15030370","article-title":"Design and development of levodopa loaded polymeric nanoparticles for intranasal delivery","volume":"15","author":"Ahmad","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.pharma.2024.07.008_bib0285","article-title":"Development of \u03b2-cyclodextrin\/chitosan-co-poly (2-acrylamide-2-methylpropane sulphonic acid) cross-linked hybrid IPN-nanogels to enhance the solubility of rosuvastatin: an in vitro and in vivo attributes","volume":"75","author":"Shoukat","year":"2022","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.pharma.2024.07.008_bib0290","doi-asserted-by":"crossref","first-page":"100612","DOI":"10.1016\/j.curtheres.2020.100612","article-title":"Chitosan-coated hydroxypropylmethyl cellulose microparticles of levodopa (and carbidopa): in vitro and rat model kinetic characteristics","volume":"93","author":"Dankyi","year":"2020","journal-title":"Curr Ther Res Clin Exp"},{"issue":"2","key":"10.1016\/j.pharma.2024.07.008_bib0295","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21020487","article-title":"Chitosan derivatives and their application in biomedicine","volume":"21","author":"Wang","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.pharma.2024.07.008_bib0300","doi-asserted-by":"crossref","DOI":"10.3390\/nano8060389","article-title":"Incorporation of levodopa into biopolymer coatings based on carboxylated carbon nanotubes for ph-dependent sustained release drug delivery","volume":"8","author":"Tan","year":"2018","journal-title":"Nanomaterials"},{"issue":"2","key":"10.1016\/j.pharma.2024.07.008_bib0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/md21020091","article-title":"Fast and sustained axonal growth by BDNF released from chitosan microspheres","volume":"21","author":"Aranaz","year":"2023","journal-title":"Mar Drugs"},{"key":"10.1016\/j.pharma.2024.07.008_bib0310","doi-asserted-by":"crossref","DOI":"10.1186\/s11671-018-2748-2","article-title":"Nanoalginates via inverse-micelle synthesis: doxorubicin-encapsulation and breast cancer cytotoxicity","volume":"13","author":"Rosch","year":"2018","journal-title":"Nanoscale Res Lett"},{"issue":"12","key":"10.1016\/j.pharma.2024.07.008_bib0315","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1166\/jbn.2016.2313","article-title":"Intranasal administration of chitosan-coated nanostructured lipid carriers loaded with GDNF improves behavioral and histological recovery in a partial lesion model of Parkinson's disease","volume":"12","author":"Gartziandia","year":"2016","journal-title":"J Biomed Nanotechnol"},{"key":"10.1016\/j.pharma.2024.07.008_bib0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2019.115161","article-title":"Conductive hydrogels based on agarose\/alginate\/chitosan for neural disorder therapy","volume":"224","author":"Alizadeh","year":"2019","journal-title":"Carbohydr Polym"},{"issue":"1","key":"10.1016\/j.pharma.2024.07.008_bib0325","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s12035-017-0728-7","article-title":"Intranasal administration of TAT-conjugated lipid nanocarriers loading GDNF for Parkinson's disease","volume":"55","author":"Hernando","year":"2018","journal-title":"Mol Neurobiol"},{"issue":"1","key":"10.1016\/j.pharma.2024.07.008_bib0330","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ejpb.2015.05.019","article-title":"Intranasal delivery of dopamine to the striatum using glycol chitosan\/sulfobutylether-\u03b2-cyclodextrin based nanoparticles","volume":"94","author":"Di Gioia","year":"2015","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.pharma.2024.07.008_bib0335","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev-med-041217-010829","article-title":"Therapeutic antisense oligonucleotides are coming of age","volume":"70","author":"Bennett","year":"2019","journal-title":"Ann Rev Med"},{"issue":"4","key":"10.1016\/j.pharma.2024.07.008_bib0340","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.biomaterials.2012.10.013","article-title":"Synthesis of TAT peptide-tagged PEGylated chitosan nanoparticles for siRNA delivery targeting neurodegenerative diseases","volume":"34","author":"Malhotra","year":"2013","journal-title":"Biomaterials"},{"issue":"12","key":"10.1016\/j.pharma.2024.07.008_bib0345","first-page":"1","article-title":"Trimethyl chitosan hydrogel nanoparticles for progesteronedelivery inneurodegenerativedisorders","volume":"11","author":"Lai","year":"2019","journal-title":"Pharmaceutics"},{"issue":"7","key":"10.1016\/j.pharma.2024.07.008_bib0350","doi-asserted-by":"crossref","DOI":"10.1007\/s11910-021-01115-0","article-title":"Effects of the menstrual cycle on neurological disorders","volume":"21","author":"Roeder","year":"2021","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"13","key":"10.1016\/j.pharma.2024.07.008_bib0355","doi-asserted-by":"crossref","DOI":"10.2174\/1389450117666161227125121","article-title":"A mini review on the chemistry and neuroprotective effects of silymarin","volume":"18","author":"Devi","year":"2017","journal-title":"Curr Drug Targets"},{"issue":"2","key":"10.1016\/j.pharma.2024.07.008_bib0360","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15020618","article-title":"Intranasal delivery of a silymarin loaded microemulsion for the effective treatment of Parkinson's disease in rats: formulation, optimization, characterization, and in vivo evaluation","volume":"15","author":"Imran","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.pharma.2024.07.008_bib0365","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3389\/fphar.2018.00422","article-title":"Anti-Parkinson potential of silymarin: mechanistic insight and therapeutic standing","volume":"9","author":"Ullah","year":"2018","journal-title":"Front Pharmacol"},{"issue":"3","key":"10.1016\/j.pharma.2024.07.008_bib0370","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s12640-018-9978-z","article-title":"Low molecular weight sulfated chitosan: neuroprotective effect on rotenone-induced in vitro Parkinson's disease","volume":"35","author":"Manigandan","year":"2019","journal-title":"Neurotox Res"},{"key":"10.1016\/j.pharma.2024.07.008_bib0375","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.ijbiomac.2022.10.204","article-title":"A green and facile approach for fabrication of biocompatible anti-Parkinson chitosan-gelatin-green tea extract composite particles with neuroprotective and Neurotherapeutic effects: in vitro evaluation","volume":"224","author":"Bavi","year":"2023","journal-title":"Int J Biol Macromol"},{"issue":"6","key":"10.1016\/j.pharma.2024.07.008_bib0380","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23061297","article-title":"Beneficial effects of green tea catechins on neurodegenerative diseases","volume":"23","author":"Pervin","year":"2018","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.pharma.2024.07.008_bib0385","article-title":"Ginkgo biloba in the aging process: a narrative review","volume":"11","author":"Barbalho","year":"2022","journal-title":"Antioxidants (Basel, Switzerland)"},{"key":"10.1016\/j.pharma.2024.07.008_bib0390","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.ijbiomac.2021.10.023","article-title":"Preparation of chitosan nanoparticles as Ginkgo Biloba extract carrier: in vitro neuroprotective effect on oxidative stress-induced human neuroblastoma cells (SH-SY5Y)","volume":"192","author":"Karavelioglu","year":"2021","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.pharma.2024.07.008_bib0395","article-title":"Chitosan\u2013coated nanostructured lipid carriers for effective brain delivery of Tanshinone IIA in Parkinson's disease: interplay between nuclear factor\u2013kappa \u03b2 and cathepsin B","author":"Hassan","year":"2023","journal-title":"Drug Deliv Transl Res"},{"issue":"23","key":"10.1016\/j.pharma.2024.07.008_bib0400","doi-asserted-by":"crossref","first-page":"10488","DOI":"10.1021\/acs.jmedchem.8b01018","article-title":"Tanshinone-IIA-based analogues of imidazole alkaloid act as potent inhibitors to block breast cancer invasion and metastasis in vivo","volume":"61","author":"Wu","year":"2018","journal-title":"J Med Chem"},{"issue":"1","key":"10.1016\/j.pharma.2024.07.008_bib0405","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40824-023-00347-0","article-title":"Bioactive self-healing hydrogel based on tannic acid modified gold nano-crosslinker as an injectable brain implant for treating Parkinson's disease","volume":"27","author":"Xu","year":"2023","journal-title":"Biomater Res"},{"issue":"10","key":"10.1016\/j.pharma.2024.07.008_bib0410","doi-asserted-by":"crossref","first-page":"5838","DOI":"10.1039\/D1FO04374A","article-title":"Chitosan oligosaccharides exert neuroprotective effects via modulating the PI3K\/Akt\/Bcl-2 pathway in a Parkinsonian model","volume":"13","author":"Wang","year":"2022","journal-title":"Food Funct"}],"container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000345092400107X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000345092400107X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T21:29:20Z","timestamp":1739654960000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000345092400107X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":82,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S000345092400107X"],"URL":"https:\/\/doi.org\/10.1016\/j.pharma.2024.07.008","relation":{},"ISSN":["0003-4509"],"issn-type":[{"value":"0003-4509","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhancing drug bioavailability for Parkinson's disease: The promise of chitosan delivery mechanisms","name":"articletitle","label":"Article Title"},{"value":"Annales Pharmaceutiques Fran\u00e7aises","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharma.2024.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Acad\u00e9mie Nationale de Pharmacie. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}